Soluble Collagen VI treatment enhances mesenchymal stem cells expansion for engineering cartilage
Open Access
- 21 September 2017
- journal article
- research article
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 2 (3) , 278-284
Abstract
Bone Marrow‐derived mesenchymal stem cells (BM‐MSC) are an attractive source for cell‐based therapies in cartilage injury owing to their efficient differentiation into chondrocytes and their immune‐suppressive abilities. However, their clinical use is hampered by a scarcity of cells leading to compromised efficacy. While expansion of human MSC ex vivo can potentially overcome the scarcity of cells, current methods lead to a rapid loss of the stem cell properties. In this study, we report soluble Collagen VI (cartilage pericellular matrix component) as a potential biologic that can expand the MSC population while maintaining the stem cell phenotype as confirmed by expression of the stem cell markers CD105 and CD90. Short‐term treatment with Collagen VI additionally retains the potential of MSC to differentiate into mature chondrocytes in pellet culture. Cartilage pellets generated from MSC treated with Collagen VI or control express comparable amounts of the chondrogenic markers Collagen II, Aggrecan and Sox9, and the extracellular glycosaminoglycans. Our observations confirm that the use of the endogenous and cartilage‐specific factor Collagen VI is valuable for a rapid and efficient expansion of MSC for potential use in cartilage regeneration and osteoarthritis.Keywords
This publication has 22 references indexed in Scilit:
- Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challengesBone, 2016
- Stem Cell Therapies in Clinical Trials: Progress and ChallengesCell Stem Cell, 2015
- Long-Term Expansion, Enhanced Chondrogenic Potential, and Suppression of Endochondral Ossification of Adult Human MSCs via WNT Signaling ModulationStem Cell Reports, 2015
- The structure and function of the pericellular matrix of articular cartilageMatrix Biology, 2014
- Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapyWorld Journal of Stem Cells, 2014
- Unlike Bone, Cartilage Regeneration Remains ElusiveScience, 2012
- Post‐traumatic osteoarthritis: Improved understanding and opportunities for early interventionJournal of Orthopaedic Research, 2011
- Treatment of articular cartilage lesions of the kneeInternational Orthopaedics, 2010
- FGF-4 increasesin vitroexpansion rate of human adult bone marrow-derived mesenchymal stem cellsGrowth Factors, 2007
- Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2Experimental Cell Research, 2003